Clinical Trial Update: Combined Ranibizumab and Iluvien for Diabetic Macular Oedema [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating combined ranibizumab and Iluvien for diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Diabetic Macular Edema

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Imperial College London | Conditions: Diabetic Macular Edema, Diabetes | Phase 2, Phase 3 | Status: WITHDRAWN